ReportWire

Tag: COVID

  • FDA OKs Novavax COVID Vaccine as First Booster Shot

    FDA OKs Novavax COVID Vaccine as First Booster Shot

    By Cara Murez 

    HealthDay Reporter

    THURSDAY, Oct. 20, 2022 (HealthDay News) – Americans will now have another choice if they want a COVID booster shot.

    On Wednesday, the U.S. Food and Drug Administration approved Novavax Inc.’s protein-based vaccine as a first booster dose. Until now, it had only been approved as a two-dose primary series.

    “The U.S. now has access to the Novavax COVID-19 Vaccine, adjuvanted, the first protein-based option, as a booster,” Novavax President and CEO Stanley Erck said in a news release. “According to CDC data, almost 50 percent of adults who received their primary series have yet to receive their first booster dose. Offering another vaccine choice may help increase COVID-19 booster vaccination rates for these adults.”

    The Novavax booster could be used by adults who can’t find or are not able to use an mRNA boosters from Pfizer or Moderna. It’s also available to people who prefer this vaccine for a booster over the mRNA options. The Novavax booster can be given at least six months after the primary series.

    The Novavax vaccine uses a more traditional approach to fighting the virus, teaching the immune system to recognize modified fragments of the coronavirus spike protein.

    Scientists created the vaccine from a genetic sequence of the original strain of the virus. Vaccines that fight hepatitis B and pertussis are also made in this way.

    Public health officials are encouraging people to get their boosters. About 68% of U.S. residents have had an initial COVID vaccine series, but only 33.5% have received boosters, CDC data shows. Novavax’s vaccine is one of four options available in the United States now.

    More information

    The U.S. Centers for Disease Control and Prevention has more on COVID-19 vaccines.

     

     

    SOURCE: CNN

    Source link

  • Two new COVID variants are spreading fast in New York region and could account for about 37% of new cases

    Two new COVID variants are spreading fast in New York region and could account for about 37% of new cases

    The two newly identified omicron subvariants, dubbed BQ.1 and BQ.1.1, are spreading fast in the New York region and could account for about 37% of new cases, according to Centers for Disease Control and Prevention data crunched by NBC News.

    The two variants accounted for 11.5% and 8% of new cases, respectively, that were recorded in the area in the week ending Oct. 15, up from 4.1% and 1.9% two weeks earlier. The New York area includes New Jersey, Puerto Rico and the Virgin Islands.

    Combined, they accounted for 11.4% of overall U.S. cases in the same week. Before last Friday’s data release, they were included in BA.5 variant data, as the numbers were too small to break out. BQ.1 was first identified by researchers in early September and has been found in the U.K. and Germany, among other places. The CDC is updating the numbers every Friday.

    “When you get variants like that, you look at what their rate of increase is as a relative proportion of the variants, and this has a pretty troublesome doubling time,” Anthony Fauci, President Joe Biden’s chief medical adviser, said in an interview with CBS News earlier this week.

    The news comes as experts fear another wave of cases during the winter months as colder weather forces people indoors and families gather for holidays.

    U.S. known cases of COVID are continuing to ease and now stand at their lowest level since mid-April, although the true tally is likely higher given how many people overall are testing at home, where the data are not being collected.

    The daily average for new cases stood at 37,888 on Tuesday, according to a New York Times tracker, down 15% from two weeks ago. Cases are currently rising in 10 states: Nevada, New Hampshire, New Mexico, Oklahoma, Maryland, Wisconsin, Illinois, Vermont, Kansas and Florida. Cases are also rising in Washington, D.C.

    The daily average for hospitalizations was down 6% to 25,845, although hospitalizations are up in many northeastern states, including Rhode Island, New Hampshire, New Jersey, New York, Massachusetts, Delaware, Pennsylvania and Maine.

    The daily average for deaths is down 3% to 382.

    In other news, the World Health Organization said its emergency committee came away from a meeting last week with the determination that the pandemic remains a global health emergency, despite recent progress.

    WHO Director General Tedros Adhanom Ghebreyesus said he agreed with that decison.

    “The committee emphasized the need to strengthen surveillance and expand access to tests, treatments and vaccines for those most at-risk, and for all countries to update their national preparedness and response plans,” Tedros told reporters at a briefing.

    “While the global situation has obviously improved since the pandemic began, the virus continues to change, and there remain many risks and uncertainties,” he said. “This pandemic has surprised us before and very well could again.”

    The new bivalent vaccine might be the first step in developing annual COVID-19 shots, which could follow a similar process to the one used to update flu vaccines every year. Here’s what that process looks like, and why applying it to COVID could be challenging. Illustration: Ryan Trefes

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • Reports that a 16-year-old girl has died at a COVID quarantine center in China are causing anger after her family said their pleas for medical help were ignored, the Guardian reported. Videos of the girl have spread across Chinese social media in the last 24 hours. The distressing footage, which the Guardian said it has not been able to independently verify, shows the teenager ill, struggling to breathe and convulsing in a bunk bed at what is purported to be a quarantine center in Ruzhou, Henan province. The reports come as Communist Party leaders hold their party congress in Beijing amid anger about the country’s strict zero-COVID policy.

    • Hong Kong, which is experiencing a massive brain drain thanks to the pandemic and to political upheaval, unveiled a new visa scheme on Wednesday that aims to attract global talent, the Associated Press reported. The region’s chief executive, John Lee, said the Top Talent Pass Scheme will allow people who earn an annual salary of 2.5 million Hong Kong dollars ($318,472) or more, as well as graduates of the world’s top universities, to work or pursue opportunities in the city for two years.

    In a rare display of defiance, two banners unfurled from a highway overpass in Beijing condemned Chinese President Xi Jinping and his strict COVID policies. The protest took place days before the Communist Party congress in that city.

    • The COVID pandemic catalyzed a major shift in the way Americans live and work, and a new analysis from the Federal Reserve Bank of New York shows that workers in the U.S. are taking advantage of the widespread shift toward remote work to spend more time sleeping and engaging in leisure activities, MarketWatch’s Chris Matthews reported. “One of the most enduring shifts [resulting from the pandemic] has occurred in the workplace, with millions of employees making the switch to work from home,” wrote David Dam, a former New York Fed research analyst, in a Tuesday blog post.

    • The North Dakota Department of Health stored thousands of COVID-19 vaccine doses at incorrect temperatures or without temperature data over the past two years, according to a state audit Tuesday that said some of those vaccines were administered to patients, the AP reported. The health department disputed the findings. Tim Wiedrich, who heads the agency’s virus response, said “no non-viable vaccine” was given to patients. In responses that accompanied the audit, the department said clerical errors or other errors of documentation erroneously suggested that expired or bad doses were given.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 625.7 million on Wednesday, while the death toll rose above 6.57 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 97 million cases and 1,065,841 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 226.2 million people living in the U.S., equal to 68.1% of the total population, are fully vaccinated, meaning they have had their primary shots. Just 110.8 million have had a booster, equal to 49% of the vaccinated population, and 25.6 million of those who are eligible for a second booster have had one, equal to 39% of those who received a first booster.

    Some 14.8 million people have had a dose of the updated bivalent booster that targets omicron and its subvariants along with the original virus.

    Source link

  • Remote employees are working less, sleeping and playing more, Fed study finds

    Remote employees are working less, sleeping and playing more, Fed study finds

    The COVID-19 pandemic catalyzed a major shift in the way Americans live and work, and a new analysis from the Federal Reserve Bank of New York shows that workers in the U.S. are taking advantage of a widespread shift toward remote work to spend more time sleeping and engaging in leisure activities.

    “One of the most enduring shifts [resulting from the pandemic] has occurred in the workplace, with millions of employees making the switch to work from home,” wrote David Dam, a former New York Fed research analyst, in a Tuesday blog post.

    “Even as the pandemic has waned, more than 15 percent of full-time employees remain fully remote and an additional 30 percent work in hybrid arrangements,” he wrote. “These changes have substantially reduced time spent commuting to work; in the aggregate, Americans now spend 60 million fewer hours traveling to work each day.”

    Dam and his colleagues drew on the American Time Use Survey to better understand how remote workers are using the time saved on commutes. They found “a substantial fall in time spent working,” with the “decrease in hours worked away from home only partially offset by an increase in working at home,” according to the post.


    Federal Reserve Bank of New York

    Changes in behavior differ among age groups, with younger Americans using the saved commuting time to engage in leisure activities like eating out, exercising or attending social events. Americans over the age of 30 spent more time on childcare, home maintenance and meal preparation.

    The flexibility of remote working arrangements, and the apparent fact that remote workers are able to spend less time overall working, will likely mean that workers will bargain hard to maintain the ability to work from home, Dam said.

    “The findings lend credence to the various reports on employees’ preferences for flexible work arrangements, given that cutting the commute enables people to spend their time on other activities, such as childcare or leisure,” he wrote. “This added benefit of working from home — for those who want it — will be an important consideration for the future of flexible work arrangements.”

    Source link

  • CDC identifies new COVID variants that accounted for 11.4% of new cases in week ending Oct. 15

    CDC identifies new COVID variants that accounted for 11.4% of new cases in week ending Oct. 15

    The Centers for Disease Control and Prevention said a new COVID variant dubbed BQ.1 and a descendant called BQ.1.1 have gained traction in the U.S., accounting for 11.4% of new cases across the nation in the week ending Oct. 15.

    The two variants are lineages of BA.5, the omicron subvariant that remains dominant but has shrunk to account for just 67.9% of circulating variants, the agency said in a Friday update. The CDC had previously combined BQ.1 and BQ.1.1 with BA.5 cases because the numbers of the new variants were so small. BQ.1 was first identified by researchers in early September and has been found in the U.K. and Germany, among other places.

    New York and New Jersey currently have the highest proportion of BQ.1 and BQ.1.1 infections, at about 20% of overall cases, according to CDC estimates.

    “When you get variants like that, you look at what their rate of increase is as a relative proportion of the variants, and this has a pretty troublesome doubling time,” Anthony Fauci, President Joe Biden’s chief medical adviser, said in an interview with CBS News. 

    Adding to concerns, the variant seems “to elude important monoclonal antibodies,” he added.

    Fauci is confident that Moderna
    MRNA,
    +3.92%
    ,
    as well as Pfizer
    PFE,
    +1.84%

    and German partner BioNTech
    BNTX,
    +2.45%
    ,
    will be able to update boosters to target the new subvariant. “The somewhat encouraging news is that it’s a BA.5 sublineage, so there are almost certainly going to be some cross-protections that you can boost up,” he said.

    So far, only 14.8 million people living in the U.S. have taken advantage of the new bivalent boosters that were authorized by the Food and Drug Administration in late August. That’s equal to about 7% of the 209 million who were initially eligible.

    The FDA authorized the Pfizer booster for use in people aged 12 and older and the Moderna booster for adults aged 18 and older. Last week, the FDA added children aged 5 to 11 to the Pfizer program and children aged 6 through 17 to the Moderna one.

    Experts are concerned that the low number of vaccinations is due to a sense that the pandemic is over and no longer poses a major risk for most people. U.S. cases are steadily declining and now stand at their lowest level since mid-April; however, the true tally is likely higher than the official count, because many people are testing at home, where data are not being collected.

    The daily average for new cases stood at 37,649 on Sunday, down 19% from two weeks ago, according to a New York Times tracker.

    The daily average for hospitalizations was down 5% to 26,475, while the daily average for deaths was down 8% to 374.

    But cold weather is expected to bring a new wave of cases, and hospitalizations are rising again in much of the Northeast, the Times tracker is showing.

    “That’s the thing that’s so frustrating for me and for my colleagues who are involved in this, is that we have the capability of mitigating against this. And the uptake of the new bivalent vaccine is not nearly as high as we would like it to be,” said Fauci.

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • Moderna and Gavi, the Vaccine Alliance, which is supplying vaccines to low- and middle-income countries, have agreed to cancel remaining orders under their 2022 COVID-19 vaccine agreement given “sufficient supply.” The biotechnology company has supplied Gavi with nearly 70 million doses of COVID-19 vaccines, in addition to facilitating the donation of more than 100 million doses. Moderna and Gavi said they will create a new framework that enables Gavi to buy up to 100 million COVID-19 vaccine doses in 2023. 

    • The World Health Organization, the Food and Agriculture Organization of the United Nations, the United Nations Environment Program and the World Organization for Animal Health on Monday launched a new initiative that aims to address health threats to humans, animals, plants and the environment. The One Health Joint Plan of Action “aims to create a framework to integrate systems and capacity so that we can collectively better prevent, predict, detect, and respond to health threats,” the four agencies said in a statement.

    • China is doubling down on its zero-COVID strategy as a historic Communist Party congress opens in Beijing, BBC News reported. Zero COVID was a “people’s war to stop the spread of the virus,” said President Xi Jinping as he kicked off the meeting. There is increasing public fatigue over lockdowns and travel restrictions, and Beijing has come under strict security measures ahead of the congress, sparking frustration in the city, including a rare and dramatic public protest on Thursday criticizing Xi and his strategy.

    In a rare display of defiance, two banners were unfurled from a highway overpass in Beijing condemning Chinese President Xi Jinping and his strict COVID-19 policies. The protest took place days before the expected extension of Xi’s tenure.

    • Airline stocks rallied Monday after data showed that on Sunday, more people flew than on any other day since before the pandemic. Data from the Transportation Security Administration showed that 2.495 million travelers went through TSA checkpoints on Sunday, which is just above the previous 2022 high of 2.490 million on July 1 and the most since Feb. 11, 2020, which was exactly one month before the World Health Organization declared COVID-19 a global pandemic. In comparison, the day with the fewest travelers since the start of the pandemic was April 12, 2022, with 87,534 people traveling. And in 2019, there were 116 days of more travelers than Sunday, while the average for that year was 2.306 million. The U.S. Global Jets ETF
    JETS,
    +2.02%

     was up 2.2%.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 624.7 million on Monday, while the death toll rose above 6.56 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 96.9 million cases and 1,065,118 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 226.2 million people living in the U.S., equal to 68.1% of the total population, are fully vaccinated, meaning they have had their primary shots. Just 110.8 million have had a booster, equal to 49% of the vaccinated population, and 25.6 million of those who are eligible for a second booster have had one, equal to 39% of those who received a first booster.

    Source link

  • Ringo Starr Has Covid-19 Rebound, Cancels 2022 Tour

    Ringo Starr Has Covid-19 Rebound, Cancels 2022 Tour

    You know it don’t come easy. That’s what legendary singer, songwriter, and drummer Ringo Starr first sang in 1971. It’s also what can often be said about having Covid-19, especially when you suffer a Covid-19 rebound, something that Starr apparently now is experiencing. And this rebound has prompted Starr to cancel the rest of his 2022 North American tour. That’s essentially what the rock super-Starr tweeted on October 13:

    Starr’s recent battle with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began when he was diagnosed with Covid-19 sometime before an October 3 press release. That press release had indicated that Starr’s Covid-19 diagnosis would force him and his All Starr Band to cancel shows from October 2 through October 9. This included shows in the U.S. (Minnesota) and Canada (Manitoba, Saskatchewan, Alberta, and British Columbia.)

    Then seven days later, on October 10, Starr posted on Instagram that he’s “On the road again I will see you in Seattle on Tuesday the 11th Portland Wednesday I am negative peace and love everybody thanks for waiting Ringo [sic]” as you can see here:

    Presumably “negative peace” didn’t mean war but instead meant that he had tested negative for Covid-19 and would be having fans lend them his ears so that he could sing them a song in Seattle on October 11. But that resumption turned out to be short-lived as three days later instead of singing “Back Off Boogaloo,” the drumming Starr indicated on Twitter that he was back with Covid-19.

    The 82-year-old Starr, who first rose to prominence in the 1960’s as the drummer for a band that you may or may not have heard of called The Beatles, is at higher risk for more severe Covid-19 outcomes given his age. However, he has gotten at least the primary two-dose series of Covid-19 vaccines. That’s based on what he had told Patrick Ryan in a interview published in USA Today on March 17, 2021. Back then Starr had said, “I’ve got both jabs and I’m feeling groovy.” When Ryan had asked him about side effects from the vaccine, Starr had replied, “Bad arm for the first one. And then the second one, with the doctor telling you, “You may feel fluish.” Nothing! Nothing! I felt let down.” Star added the following as well: “It was difficult trying to sleep on that side, but by 5 o’clock (the next day), it had gone. So I got away lightly, thank you, Lord. I think that’s because of the broccoli.,” referring to his blueberries, broccoli, and other veggies and fruit diet. Yes, whenever anything good happens in life, it’s always because of the broccoli, right.

    That was before recommendations for Covid-19 boosters had emerged. Having gotten vaccinated should offer him at least some protection against more severe Covid-19. But the level of protection will depend on how long ago his last Covid-19 vaccine dose was, no matter how much broccoli you eat.

    Staying up to date on Covid-19 vaccinations is important because, guess what, the Covid-19 pandemic ain’t over. It’s still going on, no matter what some political leaders may try to drum into your heads. And the concern right now is that yet another Covid-19 surge may right around the corner.

    Remember, while vaccination can offer you protection against more severe Covid-19, it’s not like being in a Yellow Submarine with the virus being outside. Vaccination won’t offer you 100% protection. With upswings in Covid-19 already occurring in Europe, you’ll need a little help from you friends in the coming months. It will help to not only maintain Covid-19 precautions such as wearing a face mask while indoors, maintaining appropriate levels of social distancing, and staying up-to-date on vaccination but also have others around you to do such things too. Recall all that “we’re all in this together” talk back in 2020? Well, it hasn’t become “every person for himself or herself” or “bleep everyone else.”

    Starr’s Covid-19 rebound also is a reminder that a negative Covid-19 test may not mean that you are done with Covid-19 after being infected with the SARS-CoV-2. False negatives can occur. Plus, by now, you’ve probably heard of quite a few Covid-19 rebound cases where people first test positive then test negative only to test positive again later. So even though it may not come easy to keep yourself isolated for a little longer (at least ten days) than is being recommended by some and confirming that you indeed are staying Covid-19 negative, doing so can be make sure that you aren’t giving the SARS-CoV-2 a tour around other people.

    Bruce Y. Lee, Senior Contributor

    Source link

  • Medium COVID Could Be the Most Dangerous COVID

    Medium COVID Could Be the Most Dangerous COVID

    I am still afraid of catching COVID. As a young, healthy, bivalently boosted physician, I no longer worry that I’ll end up strapped to a ventilator, but it does seem plausible that even a mild case of the disease could shorten my life, or leave me with chronic fatigue, breathing trouble, and brain fog. Roughly one in 10 Americans appears to share my concern, including plenty of doctors. “We know many devastating symptoms can persist for months,” the physician Ezekiel Emanuel wrote this past May in The Washington Post. “Like everyone, I want this pandemic nightmare to be over. But I also desperately fear living a debilitated life of mental muddle or torpor.”

    Recently, I’ve begun to think that our worries might be better placed. As the pandemic drags on, data have emerged to clarify the dangers posed by COVID across the weeks, months, and years that follow an infection. Taken together, their implications are surprising. Some people’s lives are devastated by long COVID; they’re trapped with perplexing symptoms that seem to persist indefinitely. For the majority of vaccinated people, however, the worst complications will not surface in the early phase of disease, when you’re first feeling feverish and stuffy, nor can the gravest risks be said to be “long term.” Rather, they emerge during the middle phase of post-infection, a stretch that lasts for about 12 weeks after you get sick. This period of time is so menacing, in fact, that it really ought to have its own, familiar name: medium COVID.

    Just how much of a threat is medium COVID? The answer has been obscured, to some extent, by sloppy definitions. A lot of studies blend different, dire outcomes into a single giant bucket called “long COVID.” Illnesses arising in as few as four weeks, along with those that show up many months later, have been considered one and the same. The CDC, for instance, suggested in a study out last spring that one in five adults who get the virus will go on to suffer any of 26 medical complications, starting at least one month after infection, and extending up to one year. All of these are called “post-COVID conditions, or long COVID.” A series of influential analyses looking at U.S. veterans described an onslaught of new heart, kidney, and brain diseases (even among the vaccinated) across a similarly broad time span. The studies’ authors refer to these, grouped together, as “long COVID and its myriad complications.”

    But the risks described above might well be most significant in just the first few weeks post-infection, and fade away as time goes on. When scientists analyzed Sweden’s national health registry, for example, they found that the chance of developing pulmonary embolism—an often deadly clot in the lungs—was a startling 32 times higher in the first month after testing positive for the virus; after that, it quickly diminished. The clots were only two times more common at 60 days after infection, and the effect was indistinguishable from baseline after three to four months. A post-infection risk of heart attack and stroke was also evident, and declined just as expeditiously. In July, U.K. epidemiologists corroborated the Swedish findings, showing that a heightened rate of cardiovascular disease among COVID patients could be detected up to 12 weeks after they got sick. Then the hazard went away.

    This is all to be expected, given that other respiratory infections are known to cause a temporary spike in patients’ risk of cardiovascular events. Post-viral blood clots, heart attacks, and strokes tend to blow through like a summer storm. A very recent paper in the journal Circulation, also based on U.K. data, did find that COVID’s effects are longer-lasting, with a heightened chance of such events that lasts for almost one full year. But even in that study, the authors see the risk fall off most dramatically across the first two weeks. I’ve now read dozens of similar analyses, using data from many countries, that agree on this basic point: The greatest dangers lie in the weeks, not months, after a COVID infection.

    Yet many have inferred that COVID’s dangers have no end. “What’s particularly alarming is that these are really life-long conditions,” Ziyad Al-Aly, the lead researcher on the veterans studies, told the Financial Times in August. A Cleveland Clinic cardiologist has suggested that catching SARS-CoV-2 might even become a greater contributor to cardiovascular disease than being a chronic smoker or having obesity. But if experts who hold this assumption are correct—and the mortal hazards of COVID really do persist for a lifetime (or even many months)—then it’s not yet visible at the health-system level. By the end of the Omicron surge last winter, one in four Americans—about 84 million people—had been newly infected with the coronavirus. This was on top of 103 million pre-Omicron infections. Yet six months after the surge ended, the number of adult emergency-room visits, outpatient appointments, and hospital admissions across the country were all slightly lower than they were at the same time in 2021, according to an industry report released last month. In fact, emergency-room visits and hospital admissions in 2021 and 2022 were lower than they’d been before the pandemic. In other words, a rising tide of long-COVID-related medical conditions, affecting nearly every organ system, is nowhere to be found.

    If mild infections did routinely lead to fatal consequences at a delay of months or years, then we should see it in our death rates, too. The number of excess deaths in the U.S.—meaning those that have occured beyond historic norms—should still be going up, long after case rates fall. Yet excess deaths in the U.S. dropped to zero this past April, about two months after the end of the winter surge, and they have stayed relatively low ever since. Here, as around the world, overall mortality rates follow acute-infection rates, but only for a little while. A second wave of deaths—a long-COVID wave—never seems to break.

    Even the most familiar maladies of “long COVID”—severe fatigue, cognitive difficulties, and breathing trouble—tend to be at their worst during the medium post-infection phase. An early analysis of symptom-tracking data from the U.K., the U.S., and Sweden found that the proportion of those experiencing COVID’s aftereffects decreased by 83 percent four to 12 weeks after illness started. The U.K. government also reported much higher rates of medium COVID, relative to long COVID: In its survey, 11 percent of people who caught the virus experienced lingering issues such as weakness, muscle aches, and loss of smell, but that rate had dropped to 3 percent by 12 weeks post-infection. The U.K. saw a slight decline in the number of people reporting such issues throughout the spring and summer; and a recent U.S. government survey found that about half of Americans who had experienced any COVID symptoms for three months or longer had already recovered.

    This slow, steady resolution of symptoms fits with what we know about other post-infection syndromes. A survey of adolescents recovering from mononucleosis, which is caused by Epstein-Barr virus, found that 13 percent of subjects met criteria for chronic fatigue syndrome at six months, but that rate was nearly halved at one year, and nearly halved again at two. An examination of chronic fatigue after three different infections—EBV, Q fever, and Ross River virus—identified a similar pattern: frequent post-infection symptoms, which gradually decreased over months.

    The pervasiveness of medium COVID does nothing to negate the reality of long COVID—a calamitous condition that can shatter people’s lives. Many long-haulers experience unremitting symptoms, and their cases can evolve into complex chronic syndromes like ME/CFS or dysautonomia. As a result, they may require specialized medical care, permanent work accommodations, and ongoing financial support. Recognizing the small chance of such tragic outcomes could well be enough to make some people try to avoid infection or reinfection with SARS-CoV-2 at all costs.

    But if you’re like me, and trying to calibrate your behaviors to meet some personally acceptable level of COVID risk, then it helps to keep in mind the difference between the virus’s medium- and long-term complications. Medium COVID may be time-limited, but it is far from rare—and not always mild. It can mean a month or two of profound fatigue, crushing headaches, and vexing chest pain. It can lead to life-threatening medical complications. It needs recognition, research, and new treatments. For millions of people, medium COVID is as bad as it gets.

    Benjamin Mazer

    Source link

  • Lots of Americans Lied to Others About COVID (Study)

    Lots of Americans Lied to Others About COVID (Study)


    By Cara Murez HealthDay Reporter

    HealthDay Reporter


    MONDAY, Oct. 10, 2022 (HealthDay News) — At the height of the COVID-19 pandemic, more than 40% of Americans were untruthful about whether they had the virus or were ignoring safety precautions, a nationwide survey shows.

    The December survey of 1,700 people found 721 respondents had either misrepresented their COVID status or failed to follow public health recommendations.

    Folks ignored quarantine rules, told someone they were about to see that they had been taking more precautions than they actually were, and didn’t mention they might or did have COVID when they entered a doctor’s office. They were also untruthful about vaccination status, claiming they were vaccinated when they weren’t or that they were unvaccinated when they had taken the jab, the survey revealed.

    The most common reasons for the lack of transparency were that people wanted to feel normal or to exercise personal freedom.

    “COVID-19 safety measures can certainly be burdensome, but they work,” said co-author Andrea Gurmankin Levy, a professor of social sciences at Middlesex Community College in Connecticut.

    Co-author Angela Fagerlin, head of population health sciences at University of Utah Health, said the survey raises concerns about how reluctance to truthfully report health status and adherence to masking, social distancing and public health measures could lengthen the pandemic and spread infectious diseases.

    “Some individuals may think if they fib about their COVID-19 status once or twice, it’s not a big deal,” Fagerlin said in a University of Utah news release. “But if, as our study suggests, nearly half of us are doing it, that’s a significant problem that contributes to prolonging the pandemic.”

    Respondents gave a variety of reasons for their deception. Among them: They didn’t think COVID was real or a big deal; they didn’t feel sick; they couldn’t miss work or stay home; they were following the advice of a public figure or celebrity; and finally, it was no one else’s business.
     

    “When people are dishonest about their COVID-19 status or what precautions they are taking, it can increase the spread of disease in their community,” Levy said in the release. “For some people, particularly before we had COVID vaccines, that can mean death.”


    Continued

    Those most likely to engage in misrepresentation included all age groups under 60 and those with a greater distrust of science. About 60% of respondents said they had sought a doctor’s advice for COVID-19 prevention or treatment.

    The study did not find an association between misrepresentation and political beliefs, party affiliation or religion.

    Fagerlin said this survey asked about a broader range of behaviors compared to previous studies on this topic and included far more participants.

    But the researchers said they could not determine if respondents answered honestly and the findings may underestimate how often people were dishonest about their health status.

    “This study goes a long way toward showing us what concerns people have about the public health measures implemented in response to the pandemic and how likely they are to be honest in the face of a global crisis,” said co-author Alistair Thorpe, a postdoctoral researcher at University of Utah Health. “Knowing that will help us better prepare for the next wave of worldwide illness.”

    The findings were published Oct. 10 in JAMA Network Open.


    More information

    The U.S. Centers for Disease Control and Prevention has more on COVID-19.

     

    SOURCE: University of Utah Health, news release, Oct. 10, 2022



    WebMD News from HealthDay



    Copyright © 2013-2022 HealthDay. All rights reserved.

    Source link

  • Weird Facts

    Weird Facts

    A man named Jeff Reitz went to Disneyland every day for over eight years, 2,995 consecutive days, and only stopped because of the COVID-19 pandemic.

    Source link

  • U.S. risks prolonging pandemic if it doesn’t back WTO push to get vaccines and treatments to lower-income countries, lawmakers warn

    U.S. risks prolonging pandemic if it doesn’t back WTO push to get vaccines and treatments to lower-income countries, lawmakers warn

    The U.S. is at risk of prolonging the COVID pandemic if it fails to back an initiative that aims to get vaccines, diagnostics and treatments to lower-income countries, a congressional group has told President Joe Biden.

    In a letter to Biden from the group led by Earl Blumenauer, a Democrat from Oregon, the group urged him to back the World Trade Organization’s agreement in June to ease exports of lifesaving therapies.

    With more than 600 million shots in arms, 21,500 free testing sites, the ability to order at-home tests for free, and more treatments available now than at any point in the pandemic, the outlook in the United States is better than ever. Unfortunately, however, the prospect for many low-income countries is not so positive — putting the United States’ own success in jeopardy,” the lawmakers wrote.

    The letter was sent ahead of a meeting of the WTO council for trade-related aspects of IP rights that is due to kick off Thursday.

    The group noted that lower-income countries are facing a higher risk of severe illness, hospitalization and death as only a small percentage of their populations are vaccinated. Just 19% of people in those countries are vaccinated, compared with about 75% in high-income countries, according to the Multilateral Leaders Taskforce on COVID-19, a joint initiative of the International Monetary Fund, the World Bank, the World Health Organization and the WTO.

    U.S. known cases of COVID are continuing to ease and now stand at their lowest level since late April, although the true tally is likely higher given how many people are testing at home, where the data are not being collected.

    The daily average for new cases stood at 43,149 on Wednesday, according to a New York Times tracker, down 23% from two weeks ago. Cases are rising in most northeastern states by 10% of more, while cases in the western states Montana, Washington and Oregon are rising.

    The daily average for hospitalizations was down 11% at 27,184, while the daily average for deaths is down 8% to 391. 

    The new bivalent vaccine might be the first step in developing annual Covid shots, which could follow a similar process to the one used to update flu vaccines every year. Here’s what that process looks like, and why applying it to Covid could be challenging. Illustration: Ryan Trefes

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • China’s huge Xinjiang region has been hit with sweeping COVID travel restrictions ahead of a key Communist Party congress later this month, the Associated Press reported. Trains and buses in and out of the region of 22 million people have been suspended, and passenger numbers on flights have been reduced to 75% of capacity in recent days, according to Chinese media reports. The region is home to minorities who have been forced into prison-like re-education centers to force them to renounce their religion, typically Islam, and allegedly subjected to human-rights abuses.

    • Five current or former Internal Revenue Service workers have been charged with fraud for illegally getting money from federal COVID-19 relief programs and using a total of $1 million for luxury items and personal trips, prosecutors said, the AP reported. The U.S. attorney’s office in Memphis said Tuesday that the five have been charged with wire fraud after they filed fake applications for the Paycheck Protection Program and the Economic Injury Disaster Loan Program, which were part of a federal stimulus package tied to the pandemic response in 2020.

    • Peloton Interactive Inc.
    PTON,
    +3.84%

    said it plans to cut about 500 jobs, roughly 12% of its remaining workforce, in the company’s fourth round of layoffs this year as the connected fitness-equipment maker tries to reverse mounting losses, the Wall Street Journal reported. After enjoying a strong run early on in the pandemic, Peloton has struggled since the start of the U.S. recovery, and CEO Barry McCarthy, who took over in February, said he is giving the unprofitable company another six months or so to significantly turn itself around and, if it fails, Peloton likely isn’t viable as a stand-alone company.

    Don’t missPeloton CEO says ‘naysayers’ are looking at the company’s $1.2 billion quarterly loss all wrong.

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 619.9 million on Wednesday, while the death toll rose above 6.55 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 96.6 million cases and 1,061,490 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 225.3 million people living in the U.S., equal to 67.9% of the total population, are fully vaccinated, meaning they have had their primary shots. Just 109.9 million have had a booster, equal to 48.8% of the vaccinated population, and 23.9 million of those who are eligible for a second booster have had one, equal to 36.6% of those who received a first booster.

    Some 7.6 million people have had a shot of one of the new bivalent boosters that target the new omicron subvariants that have become dominant around the world.

    Source link

  • Biden disappointed by ‘shortsighted’ OPEC+ cut, more SPR releases possible

    Biden disappointed by ‘shortsighted’ OPEC+ cut, more SPR releases possible

    WASHINGTON, Oct 5 (Reuters) – President Joe Biden called on his administration and Congress to explore ways to boost U.S. energy production and reduce OPEC’s control over energy prices after the cartel’s “shortsighted” production cut, the White House said on Wednesday.

    The Saudi Arabia-led OPEC+ cartel at a Vienna meeting on Wednesday ignored pleas from the White House to keep oil flowing and agreed to cut output by 2 million barrels per day, its deepest cuts in production since the 2020 COVID-19 pandemic.

    The move drew a sharp response from Biden that underscores the growing rift between the United States and Saudi Arabia on energy policy.

    Register now for FREE unlimited access to Reuters.com

    “The President is disappointed by the shortsighted decision by OPEC+ to cut production quotas while the global economy is dealing with the continued negative impact of (Russian President Vladimir) Putin’s invasion of Ukraine,” national security adviser Jake Sullivan and National Economic Council Director Brian Deese said in a statement.

    Biden warned that he will now continue to direct releases from the nation’s Strategic Petroleum Reserve “as necessary,” a shift from the White House’s previous comments that it would end the drawdown in the coming weeks.

    Earlier this year, the Biden administration announced the largest sale ever from the reserve: 180 million barrels for six months beginning in May. Last month it extended that historic sale into November as only about 155 million barrels had been sold. It now aims to sell 165 million through November.

    As a result, the amount of oil in the reserve has fallen to the lowest level since July 1984. It now holds about 416 million barrels of oil, well above what the United States is required by its membership in the International Energy Agency, at sites on the Texas and Louisiana coasts.

    Rising oil and fuel prices are a risk to Biden’s fellow Democrats as they seek to keep control of Congress in the Nov. 8 midterm elections.

    Biden also pledged to consult with Congress on additional tools to cut OPEC’s control over energy prices, a potential reference to a decades-long effort to open the cartel to antitrust lawsuits for orchestrating supply cuts.

    The so-called NOPEC bill, which has brought up numerous times over the past 20 years but never enacted, easily passed a Senate committee in May.

    The White House has previously expressed concerns about unintended consequences of the bill.

    The White House is also worried about the cut cementing Saudi Arabia’s closer cooperation with Russia, also a member of OPEC+, as oil revenues fund Moscow’s war machine in Ukraine.

    “Look it’s clear that OPEC Plus is aligning with Russia with today’s announcement,” White House spokesperson Karine-Jean Pierre told reporters aboard Air Force One on Wednesday.

    Register now for FREE unlimited access to Reuters.com

    Reporting by Susan Heavey and Jarrett Renshaw; editing by Tim Ahmann and David Gregorio

    Our Standards: The Thomson Reuters Trust Principles.

    Source link

  • Warning Signs About the First Post-pandemic Winter

    Warning Signs About the First Post-pandemic Winter

    This fall, unlike the one before it, and the one before that, America looks almost like its old self. Schools and universities are in session; malls, airports, and gyms are bustling with the pre-holiday rush; handwashing is passé, handshakes are back, and strangers are packed together on public transport, nary a mask to be seen. On its surface, the country seems ready to enjoy what some might say is our first post-pandemic winter.

    Americans are certainly acting as if the crisis has abated, and so in that way, at least, you could argue that it has. “If you notice, no one’s wearing masks,” President Joe Biden told 60 Minutes in September, after proclaiming the pandemic “over.” Almost no emergency protections against the virus are left standing; we’re dismantling the few that are. At the same time, COVID is undeniably, as Biden says, “a problem.” Each passing day still brings hundreds of deaths and thousands of hospitalizations; untold numbers of people continue to deal with long COVID, as more join them. In several parts of the country, health-care systems are struggling to stay afloat. Local public-health departments, underfunded and understaffed, are hanging by a thread. And a double surge of COVID and flu may finally be brewing.

    So we can call this winter “post-pandemic” if we want. But given the policy failures and institutional dysfunctions that have accumulated over the past three years, it won’t be anything like a pre-pandemic winter, either. The more we resist that reality, the worse it will become. If we treat this winter as normal, it will be anything but.


    By now, we’ve grown acquainted with the variables that dictate how a season with SARS-CoV-2 will go. In our first COVID winter, the vaccines had only just begun their trickle out into the public, while most Americans hadn’t yet been infected by the virus. In our second COVID winter, the country’s collective immunity was higher, but Omicron sneaked past some of those defenses. On the cusp of our third COVID winter, it may seem that SARS-CoV-2 has few plot twists left to toss us.

    But the way in which we respond to COVID could still sprinkle in some chaos. During those first two winters, at least a few virus-mitigating policies and precautions remained in place—nearly all of which have since come down, lowering the hurdles the virus must clear, at a time when America’s health infrastructure is facing new and serious threats.

    The nation is still fighting to contain a months-long monkeypox outbreak; polio continues to plague unvaccinated sectors of New York. A riot of respiratory viruses, too, may spread as temperatures cool and people flock indoors. Rates of RSV are rising; flu returned early in the season from a nearly three-year sabbatical to clobber Australia, boding poorly for us in the north. Should flu show up here ahead of schedule, Americans, too, could be pummeled as we were around the start of 2018, “one of the worst seasons in the recent past,” says Srinivasan Venkatramanan, an infectious-disease modeler at the University of Virginia and a member of the COVID-19 Scenario Modeling Hub.

    The consequences of this infectious churn are already starting to play out. In Jackson, Mississippi, health workers are watching SARS-CoV-2 and other respiratory viruses tear through children “like nothing we’ve ever seen before,” says Charlotte Hobbs, a pediatric-infectious-disease specialist at the University of Mississippi Medical Center. Flu season has yet to go into full swing, and Hobbs is already experiencing one of the roughest stretches she’s had in her nearly two decades of practicing. Some kids are being slammed with one virus after the other, their sicknesses separated by just a couple of weeks—an especially dangerous prospect for the very youngest among them, few of whom have received COVID shots.

    The toll of doctor visits missed during the pandemic has ballooned as well. Left untreated, many people’s chronic conditions have worsened, and some specialists’ schedules remain booked out for months. Add to this the cases of long COVID that pile on with each passing surge of infections, and there are “more sick people than there used to be, period,” says Emily Landon, an infectious-disease physician at the University of Chicago. That’s with COVID case counts at a relative low, amid a massive undercount. Even if a new, antibody-dodging variant doesn’t come banging on the nation’s door, “the models predict an increase in infections,” Venkatramanan told me. (In parts of Europe, hospitalizations are already making a foreboding climb.)

    And where the demand for care increases, supply does not always follow suit. Health workers continue to evacuate their posts. Some have taken early retirement, worried that COVID could exacerbate their chronic conditions, or vice versa; others have sought employment with better hours and pay, or left the profession entirely to salvage their mental health. A wave of illness this winter will pare down forces further, especially as the CDC backs off its recommendations for health-care workers to mask. At UAB Hospital, in Birmingham, Alabama, “we’ve struggled to have enough people to work,” says Sarah Nafziger, an emergency physician and the medical director for employee health. “And once we get them here, we have a hard time getting them to stay.”

    Clinical-laboratory staff at Deaconess Hospital, in Indiana, who are responsible for testing patient samples, are feeling similar strain, says April Abbott, the institution’s microbiology director. Abbott’s team has spent most of the past month below usual minimum-staffing levels, and has had to cut some duties and services to compensate, even after calling in reinforcements from other, already shorthanded parts of the lab. “We’re already at this threshold of barely making it,” Abbott told me. Symptoms of burnout have surged as well, while health workers continue to clock long hours, sometimes amid verbal abuse, physical attacks, and death threats. Infrastructure is especially fragile in America’s rural regions, which have suffered hospital closures and an especially large exodus of health workers. In Madison County, Montana, where real-estate values have risen, “the average nurse cannot afford a house,” says Margaret Bortko, a nurse practitioner and the region’s health officer and medical director. When help and facilities aren’t available, the outcome is straightforward, says Janice Probst, a rural-health researcher at the University of South Carolina: “You will have more deaths.”

    In health departments, too, the workforce is threadbare. As local leaders tackle multiple infectious diseases at once, “it’s becoming a zero-sum game,” says Maria Sundaram, an epidemiologist at the Marshfield Clinic Research Institute. “With limited resources, do they go to monkeypox? To polio? To COVID-19? To influenza? We have to choose.” Mati Hlatshwayo Davis, the director of health in St. Louis, told me that her department has shrunk to a quarter of the size it was five years ago. “I have staff doing the jobs of three to five people,” she said. “We are in absolute crisis.” Staff have left to take positions as Amazon drivers, who “make so much more per hour.” Looking across her state, Hlatshwayo Davis keeps watching health directors “resign, resign, resign.” Despite all that she has poured into her job, or perhaps because of it, “I can’t guarantee I won’t be one of those losses too.”


    This winter is unlikely to be an encore of the pandemic’s worst days. Thanks to the growing roster of tools we now have to combat the coronavirus—among them, effective vaccines and antivirals—infected people are less often getting seriously sick; even long COVID seems to be at least a bit scarcer among people who are up-to-date on their shots. But considering how well our shots and treatments work, the plateau of suffering at which we’ve arrived is bizarrely, unacceptably high. More than a year has passed since the daily COVID death toll was around 200; nearly twice that number—roughly three times the daily toll during a moderate flu season—now seems to be a norm.

    Part of the problem remains the nation’s failed approach to vaccines, says Avnika Amin, a vaccine epidemiologist at Emory University: The government has repeatedly championed shots as a “be-all and end-all” strategy, while failing to rally sufficient uptake. Boosting is one of the few anti-COVID measures still promoted, yet the U.S. remains among the least-vaccinated high-income countries; interest in every dose that’s followed the primary series has been paltry at best. Even with the allure of the newly reformulated COVID shot, “I’m not really getting a good sense that people are busting down the doors,” says Michael Dulitz, a health worker in Grand Forks, North Dakota. Nor can vaccines hold the line against the virus alone. Even if everyone got every shot they were eligible for, Amin told me, “it wouldn’t make COVID go away.”

    The ongoing dry-up of emergency funds has also made the many tools of disease prevention and monitoring more difficult to access. Free at-home tests are no longer being shipped out en masse; asymptomatic testing is becoming less available; and vaccines and treatments are shifting to the private sector, putting them out of reach for many who live in poor regions or who are uninsured and can least afford to fall ill.

    It doesn’t help, either, that the country’s level of preparedness lays out as a patchwork. People who vaccinate and mask tend to cluster, Amin told me, which means that not all American experiences of winter will be the same. Less prominent, less privileged parts of the country will quietly bear the brunt of outbreaks. “The biggest worry is the burden becoming unnoticed,” Venkatramanan told me. Without data, policies can’t change; the nation can’t react. “It’s like flying without altitude or speed sensors. You’re looking out the window and trying to guess.”


    There’s an alternative winter the country might envision—one unencumbered by the policy backslides the U.S. has made in recent months, and one in which Americans acknowledge that COVID remains not just “a problem” but a crisis worth responding to.

    In that version of reality, far more people would be up-to-date on their vaccines. The most vulnerable in society would be the most protected. Ventilation systems would hum in buildings across the country. Workers would have access to ample sick leave. Health-care systems would have excesses of protective gear, and local health departments wouldn’t want for funds. Masks would come out in times of high transmission, especially in schools, pharmacies, government buildings, and essential businesses; free tests, boosters, and treatments would be available to all. No one would be asked to return to work while sick—not just with COVID but with any transmissible disease. SARS-CoV-2 infections would not disappear, but they would remain at more manageable levels; cases of flu and other cold-weather sicknesses that travel through the air would follow suit. Surveillance systems would whir in every state and territory, ready to detect the next threat. Leaders might even set policies that choreograph, rather than simply capitulate to, how Americans behave.

    We won’t be getting that winter this year, or likely any year soon. Many policies have already reverted to their 2019 status quo; by other metrics, the nation’s well-being even seems to have regressed. Life expectancy in the U.S. has fallen, especially among Native Americans and Alaskan Natives. Institutions of health are beleaguered; community-outreach efforts have been pruned.

    The pandemic has also prompted a deterioration of trust in several mainstays of public health. In many parts of the country, there’s worry that the vaccine hesitancy around COVID has “spread its tentacles into other diseases,” Hobbs told me, keeping parents from bringing their kids in for flu shots and other routine vaccines. Mississippi, once known for its stellar rate of immunizing children, now consistently ranks among those with the fewest young people vaccinated against COVID. “The one thing we do well is vaccinate children,” Hobbs said. That the coronavirus has reversed the trend “has astounded me.” In Montana, sweeping political changes, including legislation that bans employers from requiring vaccines of any kind, have made health-care settings less safe. Fewer than half of Madison County’s residents have received even their primary series of COVID shots, and “now a nurse can turn down the Hepatitis B series,” Bortko told me. Health workers, too, feel more imperiled than before. Since the start of the pandemic, Bortko’s own patients of 30 years, “who trusted me with their lives,” have pivoted to “yelling at us about vaccination concerns and mask mandates and quarantining and their freedoms,” she told me. “We have become public enemy No. 1.”

    At the same time, many people with chronic and debilitating conditions are more vulnerable than they were before the pandemic began. The policies that protected them during the pandemic’s height are gone—and yet SARS-CoV-2 is still here, adding to the dangers they face. The losses have been written off, Bortko told me: Cases of long COVID in Madison County have been dismissed as products of “risk factors” that don’t apply to others; deaths, too, have been met with a shrug of “Oh, they were old; they were unhealthy.” If, this winter, COVID sickens or kills more people who are older, more people who are immunocompromised, more people of color, more essential and low-income workers, more people in rural communities, “there will be no press coverage,” Hlatshwayo Davis said. Americans already expect that members of these groups will die.

    It’s not too late to change course. The winter’s path has not been set: Many Americans are still signing up for fall flu and COVID shots; we may luck out on the viral evolution front, too, and still be dealing largely with members of the Omicron clan for the next few months. But neither immunity nor a slowdown in variant emergence is a guarantee. What we can count on is the malleability of human behavior—what will help set the trajectory of this winter, and others to come. The U.S. botched the pandemic’s beginning, and its middle. That doesn’t mean we have to bungle its end, whenever that truly, finally arrives.

    Katherine J. Wu

    Source link

  • Why Royal Caribbean and Carnival Stock Will Recover

    Why Royal Caribbean and Carnival Stock Will Recover

    For the past two years, since the covid pandemic hit in late-February 2020, the cruise industry has taken one punch after another. And, while the situation has improved from the extended period when cruises were not allowed to sail from United States ports, that does not mean that it’s back to 2019 for Royal Caribbean International (RCL) , Carnival Cruise Line (CCL) , and Norwegian Cruise Line (NCLH) .

    The industry has done a remarkable job bringing operations back to near-normal. All three cruise lines not only have put all their ships back in service, they’re also still moving forward with plans for new ships and other investments including improvements to private islands, and developing new ports.

    Source link

  • 1 in 5 of Americans don’t know about new omicron-targeting COVID boosters, survey finds

    1 in 5 of Americans don’t know about new omicron-targeting COVID boosters, survey finds

    About half of the American public has heard little or nothing about the new COVID-19 bivalent booster, a new survey by the Kaiser Family Foundation has found. The new booster targets the omicron variants that have become dominant around the world.

    One in five of those surveyed said they had heard “nothing at all” about the new boosters. Some 17% said they had heard “a lot” about the boosters, while 33% said they had heard “some” about the new shots. About a third said they’d already gotten the new booster or intended to do so as soon as possible.

    “Intention is somewhat higher among older adults, one of the groups most at risk for serious complications of a coronavirus infection,” the authors wrote. “Almost half (45%) of adults ages 65 and older say they have gotten the bivalent booster or intend to get it ‘as soon as possible.’”


    Source: Kaiser Family Foundation

    The news will likely disappoint health experts who cheered the regulatory authorization of the new boosters in August. The U.S. Food and Drug Administration granted emergency-use authorization to boosters developed by Moderna
    MRNA,
    +1.36%

    and by Pfizer
    PFE,
    -0.07%

    and German partner BioNTech
    BNTX,
    +1.53%

    for use in people aged 12 and older who have had an initial series of a COVID vaccine, including those who have already had one or more booster doses.

    The Centers for Disease Control and Prevention is recommending that all adults get one of the bivalent boosters at least two months after completing a primary series of shots. So far, some 7.6 million people in the U.S. have received it, according to the CDC.

    From the CDC: Stay Up to Date with COVID-19 Vaccines Including Boosters

    Once again, the country’s partisan divide is evident, with 6 in 10 Democrats saying they’ve already had the shot or will get it soon, compared with 1 in 8 Republicans.

    “Notably, 20% of Republicans say they will ‘definitely not’ get the new COVID-19 booster dose, while a further 38% of Republicans are unvaccinated or only partially vaccinated and therefore not eligible for the new updated COVID-19 booster dose,” the survey authors said.

    Also read: A common virus is putting more children in the hospital than in recent years

    In the U.S., known cases of COVID are continuing to ease and now stand at their lowest level since late April, although the true tally is likely higher given how many people are testing at home, where data are not being collected.

    The daily average for new cases stood at 47,569 on Thursday, according to a New York Times tracker, down 26% from two weeks ago and now at the lowest level since late April. Cases are rising in 14 states and are sharply higher in several. Montana leads the count with a 75% rise in the last two weeks, followed by Washington with a 48% rise. Cases are up by double digits in Rhode Island, New York, Massachusetts, New Hampshire, Vermont and New Jersey.

    The daily average for hospitalizations was down 13% to 28,639, while the daily average for deaths was down 11% to 407.

    The new bivalent vaccine might be the first step in developing annual COVID shots, which could follow a similar process to the one used to update flu vaccines every year. Here’s what that process looks like, and why applying it to COVID could be challenging. Illustration: Ryan Trefes

    Coronavirus Update: MarketWatch’s daily roundup has been curating and reporting all the latest developments every weekday since the coronavirus pandemic began

    Other COVID-19 news you should know about:

    • The U.K. is the only G-7 country whose economy is smaller now than before the pandemic, the Guardian reported, citing data released Friday by the Office for National Statistics. The ONS released figures showing that rather than the economy being 0.6% larger than it was in February 2020, a combination of a deeper recession during the pandemic and a weak recovery had left it 0.2% smaller. All the other major economies in the G-7, including France and Italy, recovered strongly enough to be larger than they were in February 2020.

    • Taiwan is the latest country to end mandatory COVID quarantines for people arriving from overseas, the Associated Press reported. Officials said that beginning Oct. 13, the previous weeklong quarantine requirement would be replaced with a seven-day self-monitoring period. A rapid antigen test will still be required upon arrival, but people showing no symptoms will be allowed to take public transportation. 

    • Germany’s health ministry is warning of a rise of COVID cases heading into the fall and is urging older people in particular to get a second booster shot, the AP reported separately. Other European countries such as France, Denmark and the Netherlands are also recording an increase in cases, German Health Minister Karl Lauterbach told reporters in Berlin. “We are clearly at the start of a winter wave,” he said.

    COVID-19 lockdowns, corruption crackdowns and more have put China’s economy on a potential crash course with the U.S. and the rest of the world, the Wall Street Journal’s Dion Rabouin explains. Illustration: David Fang

    • The first Chinese mRNA-based COVID vaccine has received government approval — in Indonesia, the New York Times reported. The shot, developed by Walvax Biotechnology
    300142,
    +0.49%
    ,
    Suzhou Abogen Biosciences and the Chinese military, was cleared this week by Indonesia for emergency use. Countries all over the world, including Indonesia, have embraced mRNA vaccines, and they are considered among the most effective vaccines that the world has to offer. But more than two years into the pandemic, they are not yet available in China, which has relied on an increasingly draconian “zero-COVID” approach to keep cases and deaths from the virus low.

    • Patriarch Kirill of Moscow, the head of the Russian Orthodox Church and a supporter of Russia’s war on Ukraine, has tested positive for COVID-19, the church’s press service said on Friday, Reuters reported. The church said Kirill, 75, a close ally of Russian President Vladimir Putin, had canceled all his planned trips and events and had “severe symptoms” requiring bed rest and isolation. It said his condition was “satisfactory.”

    Here’s what the numbers say:

    The global tally of confirmed cases of COVID-19 topped 617.3 million on Friday, while the death toll rose above 6.54 million, according to data aggregated by Johns Hopkins University.

    The U.S. leads the world with 96.3 million cases and 1,059,291 fatalities.

    The Centers for Disease Control and Prevention’s tracker shows that 225.3 million people living in the U.S., equal to 67.9% of the total population, are fully vaccinated, meaning they have had their primary shots. Just 109.9 million have had a booster, equal to 48.8% of the vaccinated population, and 23.9 million of those who are eligible for a second booster have had one, equal to 36.6% of those who received a first booster.

     

    Source link

  • COVID Attacks DNA in Heart, Unlike Flu, Study Says

    COVID Attacks DNA in Heart, Unlike Flu, Study Says

    Sept. 30, 2022 — COVID-19 causes DNA damage to the heart, affecting the body in a completely different way than the flu does, according to a recent study published in Immunology 

    The study looked at the hearts of patients who died from COVID-19, the flu, and other causes. The findings could provide clues about why coronavirus has led to complications such as ongoing heart issues.

    “We found a lot of DNA damage that was unique to the COVID-19 patients, which wasn’t present in the flu patients,” Arutha Kulasinghe, one of the lead study authors and a research fellow at the University of Queensland in Australia, told the Brisbane Times.

    “So in this study, COVID-19 and flu look very different in the way they affect the heart,” he said.

    Kulasinghe and colleagues analyzed the hearts of seven COVID-19 patients, two flu patients, and six patients who died from other causes. They used transcriptomic profiling, which looks at the DNA landscape of an organ, to investigate heart tissue from the patients.

    Due to previous studies about heart problems associated with COVID-19, he and colleagues expected to find extreme inflammation in the heart. Instead, they found that inflammation signals had been suppressed in the heart, and markers for DNA damage and repair were much higher. They’re still unsure of the underlying cause.

    “The indications here are that there’s DNA damage here, it’s not inflammation,” Kulasinghe said. “There’s something else going on that we need to figure out.”

    The damage was similar to the way chronic diseases such as diabetes and cancer appear in the heart, he said, with heart tissue showing DNA damage signals. 

    Kulasinghe said he hopes other studies can build on the findings to develop risk models to understand which patients may face a higher risk of serious COVID-19 complications. In turn, this could help doctors provide early treatment. For instance, all seven COVID-19 patients had other chronic diseases, such as diabetes, hypertension, and heart disease. 

    “Ideally in the future, if you have cardiovascular disease, if you’re obese or have other complications, and you’ve got a signature in your blood that indicates you are at risk of severe disease, then we can risk-stratify patients when they are diagnosed,” he said. 

    The research is a preliminary step, Kulasinghe said, due to the small sample size. This type of study is often difficult to conduct because researchers have to wait for the availability of organs, as well as request permission from families for post-mortem autopsies and biopsies, to be able to look at the effects on dead tissues.

    “Our challenge now is to draw a clinical finding from this, which we can’t at this stage,” he added. “But it’s a really fundamental biological difference we’re observing [between COVID-19 and flu], which we need to validate with larger studies.”

     

    Source link

  • Prominent Chinese commentator urges COVID experts to ‘speak out’

    Prominent Chinese commentator urges COVID experts to ‘speak out’

    BEIJING, Sept 26 (Reuters) – Prominent Chinese commentator Hu Xijin said on Sunday that as China ponders its COVID-19 policies, epidemic experts need to speak out and China ought to conduct comprehensive research and make any studies transparent to the public.

    Hu’s unusual call on Chinese social media for candour and transparency earned him 34,000 likes on the popular Twitter-like microblog Weibo, as well as frank responses from netizens in a normally tightly policed internet quick to censor voices deemed a risk to social stability.

    China’s top leaders warned in May amid the COVID lockdown of Shanghai and widespread restrictions in the Chinese capital Beijing that they would fight any comment or action that distorted, doubted or repudiated the country’s COVID policies. read more

    Register now for FREE unlimited access to Reuters.com

    “About the future, China needs very rational research and calculations,” said Hu, former editor-in-chief of nationalist state tabloid Global Times.

    “Experts must speak out, and the country should organise comprehensive studies and make them transparent to the public: what are the pros and cons for our common people, and what are the overall pros and cons for the country?”

    China has significantly tightened its COVID-19 policies this year to contain the spread of the highly transmissible Omicron variant even as its death toll since the pandemic began remains low – around 5,226 as of Saturday – and as many other countries let go of tough restrictions and learn to live with the coronavirus.

    “Oppose excessive epidemic prevention,” one Weibo user wrote in response to Hu’s post.

    In the name of putting the lives of people first, entire cities have been subjected to varying degrees of lockdown, while the infected or suspected cases are confined in facilities or at home, and local populations are required to take a PCR test every two to three days or be barred from public amenities and spaces. read more

    “I don’t mind being infected, but I fear you can’t help but stop me from moving freely,” another Weibo user said.

    Even Chinese-controlled Hong Kong is moving to scrap its controversial COVID-19 hotel quarantine policy for all arrivals, more than 2 1/2 years after it was first implemented, and just weeks ahead of a major Communist Party congress in Beijing next month when President Xi Jinping is expected to secure a precedent-breaking third term as China’s leader. read more

    Macau is also planning to reopen its borders to mainland tour groups in November, the Chinese special administrative region surprised with an announcement on Saturday. read more

    “The people must trust the state, but the state must also trust the understanding of the people,” Hu said.

    Register now for FREE unlimited access to Reuters.com

    Reporting by Ryan Woo; Editing by Toby Chopra and Stephen Coates

    Our Standards: The Thomson Reuters Trust Principles.

    Source link

  • The ‘End’ of COVID Is Still Far Worse Than We Imagined

    The ‘End’ of COVID Is Still Far Worse Than We Imagined

    When is the pandemic “over”? In the early days of 2020, we envisioned it ending with the novel coronavirus going away entirely. When this became impossible, we hoped instead for elimination: If enough people got vaccinated, herd immunity might largely stop the virus from spreading. When this too became impossible, we accepted that the virus would still circulate but imagined that it could become, optimistically, like one of the four coronaviruses that cause common colds or, pessimistically, like something more severe, akin to the flu.

    Instead, COVID has settled into something far worse than the flu. When President Joe Biden declared this week, “The pandemic is over. If you notice, no one’s wearing masks,” the country was still recording more than 400 COVID deaths a day—more than triple the average number from flu.

    This shifting of goal posts is, in part, a reckoning with the biological reality of COVID. The virus that came out of Wuhan, China, in 2019 was already so good at spreading—including from people without symptoms—that eradication probably never stood a chance once COVID took off internationally. “I don’t think that was ever really practically possible,” says Stephen Morse, an epidemiologist at Columbia. In time, it also became clear that immunity to COVID is simply not durable enough for elimination through herd immunity. The virus evolves too rapidly, and our own immunity to COVID infection fades too quickly—as it does with other respiratory viruses—even as immunity against severe disease tends to persist. (The elderly who mount weaker immune responses remain the most vulnerable: 88 percent of COVID deaths so far in September have been in people over 65.) With a public weary of pandemic measures and a government reluctant to push them, the situation seems unlikely to improve anytime soon. Trevor Bedford, a virologist at the Fred Hutchinson Cancer Center, estimates that COVID will continue to exact a death toll of 100,000 Americans a year in the near future. This too is approximately three times that of a typical flu year.


    I keep returning to the flu because, back in early 2021, with vaccine excitement still fresh in the air, several experts told my colleague Alexis Madrigal that a reasonable threshold for lifting COVID restrictions was 100 deaths a day, roughly on par with flu. We largely tolerate, the thinking went, the risk of flu without major disruptions to our lives. Since then, widespread immunity, better treatments, and the less virulent Omicron variant have together pushed the risk of COVID to individuals down to a flu-like level. But across the whole population, COVID is still killing many times more people than influenza is, because it is still sickening so many more people.

    Bedford told me he estimates that Omicron has infected 80 percent of Americans. Going forward, COVID might continue to infect 50 percent of the population every year, even without another Omicron-like leap in evolution. In contrast, flu sickens an estimated 10 to 20 percent of Americans a year. These are estimates, because lack of testing hampers accurate case counts for both diseases, but COVID’s higher death toll is a function of higher transmission. The tens of thousands of recorded cases—likely hundreds of thousands of actual cases every day—also add to the burden of long COVID.

    The challenge of driving down COVID transmission has also become clearer with time. In early 2021, the initially spectacular vaccine-efficacy data bolstered optimism that vaccination could significantly dampen transmission. Breakthrough cases were downplayed as very rare. And they were—at first. But immunity to infection is not durable against common respiratory viruses. Flu, the four common-cold coronaviruses, respiratory syncytial virus (RSV), and others all reinfect us over and over again. The same proved true with COVID. “Right at the beginning, we should have made that very clear. When you saw 95 percent against mild disease, with the trials done in December 2020, we should have said right then this is not going to last,” says Paul Offit, the director of the Vaccine Education Center at Children’s Hospital of Philadelphia. Even vaccinating the whole world would not eliminate COVID transmission.

    This coronavirus has also proved a wilier opponent than expected. Despite a relatively slow rate of mutation at the beginning of the pandemic, it soon evolved into variants that are more inherently contagious and better at evading immunity. With each major wave, “the virus has only gotten more transmissible,” says Ruth Karron, a vaccine researcher at Johns Hopkins. The coronavirus cannot keep becoming more transmissible forever, but it can keep changing to evade our immunity essentially forever. Its rate of evolution is much higher than that of other common-cold coronaviruses. It’s higher than that of even H3N2 flu—the most troublesome and fastest-evolving of the influenza viruses. Omicron, according to Bedford, is the equivalent of five years of H3N2 evolution, and its subvariants are still outpacing H3N2’s usual rate. We don’t know how often Omicron-like events will happen. COVID’s rate of change may eventually slow down when the virus is no longer novel in humans, or it may surprise us again.

    In the past, flu pandemics “ended” after the virus swept through so much of the population that it could no longer cause huge waves. But the pandemic virus did not disappear; it became the new seasonal-flu virus. The 1968 H3N2 pandemic, for example, seeded the H3N2 flu that still sickens people today. “I suspect it’s probably caused even more morbidity and mortality in all those years since 1968,” Morse says. The pandemic ended, but the virus continued killing people.

    Ironically, H3N2 did go away during the coronavirus pandemic. Measures such as social distancing and masking managed to almost entirely eliminate the flu. (It has not disappeared entirely, though, and may be back in full force this winter.) Cases of other respiratory viruses, such as RSV, also plummeted. Experts hoped that this would show Americans a new normal, where we don’t simply tolerate the flu and other respiratory illnesses every winter. Instead, the country is moving toward a new normal where COVID is also something we tolerate every year.

    In the same breath that President Biden said, “The pandemic is over,” he went on to say, “We still have a problem with COVID. We’re still doing a lot of work on it.” You might see this as a contradiction, or you might see it as how we deal with every other disease—an attempt at normalizing COVID, if you will. The government doesn’t treat flu, cancer, heart disease, tuberculosis, hepatitis C, etc., as national emergencies that disrupt everyday life, even as the work continues on preventing and treating them. The U.S.’s COVID strategy certainly seems to be going in that direction. Broad restrictions such as mask mandates are out of the question. Interventions targeted at those most vulnerable to severe disease exist, but they aren’t getting much fanfare. This fall’s COVID-booster campaign has been muted. Treatments such as bebtelovimab and Evusheld remain on shelves, underpublicized and underused.

    At the same time, hundreds of Americans are still dying of COVID every day and will likely continue to die of COVID every day. A cumulative annual toll of 100,000 deaths a year would still make COVID a top-10 cause of death, ahead of any other infectious disease. When the first 100,000 Americans died of COVID, in spring 2020, newspapers memorialized the grim milestone. The New York Times devoted its entire front page to chronicling the lives lost to COVID. It might have been hard to imagine, back in 2020, that the U.S. would come to accept 100,000 people dying of COVID every year. Whether or not that means the pandemic is over, the second part of the president’s statement is harder to argue with: COVID is and will remain a problem.

    Sarah Zhang

    Source link

  • Winsor Learning Releases Free Professional Development Resource for Administrators and Teachers of Reading in Response to Steep Declines in National Reading Scores

    Winsor Learning Releases Free Professional Development Resource for Administrators and Teachers of Reading in Response to Steep Declines in National Reading Scores

    90-minute Science of Reading-based training now available for download at no cost to teachers, schools

    Press Release


    Sep 12, 2022

    Today, in the wake of devastating recent news about the nation’s reading test scores, Minnesota-based Winsor Learning, the nation’s leading expert and provider of science-based reading instruction and teacher training, announced the release of a new and entirely free professional development resource for administrators and teachers. The 90-minute Science of Reading-based training is now available for download at no cost to teachers, administrators, tutors, and other teachers of reading.

    To download the resource, go to: https://members.winsorlearning.com/5-strategies-for-teachers/

    The most recent results of National Association of Education Progress (NAEP) testing indicate performance levels of 9-year-olds in math and reading dropping to levels not seen in more than two decades. The declines include nearly all races and income levels and are the most steep for at-risk and already lower-performing students.

    “We cannot afford to lose a generation of proficient readers. As a company, we are working to do all we can to support teachers, parents, and schools as the nation seeks to recover from the devastating impacts of the COVID crisis. Reading is the gateway to all else, and our mission — first and foremost — is to make sure every student becomes a successful reader. As we surveyed the landscape and assessed the resources we could deliver to support our nation’s educators, we knew our world-class training could make a difference,” said Amanda Burnette, President and CEO of Winsor Learning, a former public school administrator and internationally recognized expert on reading instruction.

    This is not the first time Winsor Learning has provided its resources at no cost in response to COVID. In March 2020, as the pandemic began to unfold, Winsor Learning released free online professional development opportunities for teachers. More than 10,000 educators participated in the training over the course of four weeks, with registrations from all 50 states, the District of Columbia, Puerto Rico, and Canada.

    Winsor Learning provides Orton-Gillingham, science-based reading, teaching materials, and professional development using its best-in-class Sonday System® programs and training. Educational experts at industry-leading organizations such as the National Center for Learning Disabilities and the International Dyslexia Association have deemed the Sonday System® a program that is based on the Science of Reading and contains the required elements for teaching reading identified by the Nation Reading Panel. Winsor Learning, the publisher of the Sonday System, believes in giving children their best chance to succeed in school. Sonday System is a simple, cost-effective tool for K-12 educators to identify and quickly intervene with struggling readers, as well as teach reading to all children using proven science-based multi-sensory strategies.

    CONTACT: Zeke Stokes at (202) 834-9048 or media@winsorlearning.com

    Source: Winsor Learning

    Source link

  • ioAirFlow Announces New COVID-19 Risk Assessment Solution for Schools

    ioAirFlow Announces New COVID-19 Risk Assessment Solution for Schools

    Canadian startup’s focus on air quality, COVID-19 transmission risk mitigation in response to international calls for better monitoring in buildings

    Press Release


    Jan 18, 2022

    In response to the rapid spread of the COVID-19 Omicron variant, Canadian data intelligence company ioAirFlow is heeding the call from health organizations worldwide for better building ventilation monitoring to mitigate the transmission risk of COVID-19 in schools.

    Founded in 2016, Winnipeg, Canada-based ioAirFlow was launched on the premise of improving air quality, efficiency and performance gaps in commercial buildings. The company’s solution includes a rapidly deployable and affordable test solution that can run in virtually any building worldwide.

    Their most current building performance monitoring platform provides detailed and actionable analysis specific to CO2 monitoring and ventilation efficacity, with a focus on identifying areas of higher transmission risk of COVID-19 and other airborne infectious diseases.

    “There has never been a more critical time to improve air quality and reduce COVID-19 transmission risk”, said ioAirFlow CEO Matt Schaubroeck. “In North America, it is widely accepted that buildings and workplaces with poor indoor air quality accelerate the spread of airborne diseases like COVID-19 due to inadequate ventilation and outdated mechanical and HVAC systems.”

    Last month, a study from the Swiss Federal Laboratories for Materials Science and Technology indicated that “poorly ventilated school classrooms record up to six times as many COVID-19 cases compared with those which are regularly aired.”

    In response, major health and building standards organizations, including the Centre for Disease Control and the American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE) have released international pleas for more trending and monitoring of ventilation, temperature, and humidity levels in schools and classrooms to mitigate risk of airborne pathogen transmission. 

    “We wanted to test our district’s schools to ensure that our space was safe for students and teachers”, said Tim Stefanishyn, Superintendent of the Whiteshell School District. “ioAirFlow’s data analysis allowed us to understand how the buildings’ ventilation systems were operating and what we could do to improve the indoor air quality of the spaces.”

    Since launching its platform in June 2021, ioAirFlow has been implemented in numerous buildings across North America, including a growing number of schools. The newest releases aim to enable buildings not currently equipped with permanent building monitoring systems to monitor indoor environmental quality and efficiency metrics and make smarter and safer building improvements. 

    “The lack of data available around air quality in schools is a significant barrier to having students and teachers back to a safe in-person learning environment”, said Albert Behr, industry-leading technology commercialization expert. “The solution developed by ioAirFlow is a much-needed technology application to bring reliable and affordable air quality data to buildings that desperately need it to navigate the realities of living in the COVID-19 pandemic.”

    About ioAirFlow

    ioAirFlow’s digital analysis platform identifies indoor environmental quality issues in commercial buildings including performance, energy efficiency, and air quality measurements. Using wireless sensors and a proprietary data analysis platform, the company identifies building problems faster and more accurately than manual energy audits, and at a fraction of the cost of permanent monitoring solutions.

    Source: ioAirFlow

    Source link

  • Community Heroes Celebrate North Carolina Dream Wedding at Castle Ladyhawke

    Community Heroes Celebrate North Carolina Dream Wedding at Castle Ladyhawke

    Throughout the COVID-19 pandemic in 2020, millions of Americans were forced to put their dreams on hold. Many feared those dreams may never come true. However, even through the most difficult of times, love always finds a way to prevail. To celebrate the love and resilience shown by frontline workers, Castle Ladyhawke at Bear Lake Reserve and the Jackson County Tourism Development Authority partnered to hold a nationwide contest for a dream wedding at Castle Ladyhawke

    Press Release


    Nov 16, 2021

    On November 4, contest winners and now newlyweds Kayla and Jose Arellano celebrated their special day at Castle Ladyhawke; a day nearly two years in the making. Jose and Kayla got engaged on Dec. 1, 2019, and had planned to get married in October 2020 before COVID changed everything. During the height of the pandemic, Kayla worked tirelessly as an ER/NICU nurse while Jose’s job needed him more than ever to help keep essential workers and families connected. On top of that, as Kayla had been taking care of premature babies in the NICU, she had one of her own. Kayla and Jose welcomed their baby girl, Koraline, into the world on Oct. 31, 2020. After a 76-day NICU stay, she’s fully healthy and was able to be a special part of this magical day.

    Valued at $40,000 the all-inclusive wedding package included a wedding planner, catering, photographers, videographers, florals, live music, and independent singer/songwriter Matt Stillwell. Matt Stillwell’s performance included a song he wrote for the bride and groom’s first dance, titled “Spend Forever”. With 100 of Kayla and Jose’s closest friends and family in attendance, it was truly a memorable night for everyone involved.

    “The castle was bursting with magic tonight; it was truly a dream come true.” – Kayla and Jose Arellano

    Castle Ladyhawke, North Carolina’s premier wedding and special event venue, is an authentic period-designed Scottish Border Castle nestled against the backdrop of the Blue Ridge Mountains and conveniently connected to the stunning Bear Lake Reserve gated community. To find out about its history, view photos, and learn more about our contest winners, visit CastleLadyhawke.com

    About Bear Lake Reserve
    Bear Lake Reserve is a premier luxury destination set within the jewel of Jackson County. Its 2100 acres of natural wooded beauty along the shores of Bear Creek Lake offers a secluded getaway in the mountains with all the amenities of a luxury resort including golf, pickleball/tennis, water sports, hiking, swimming, and more. To learn more or book a vacation or tour, visit www.BearLakeReserve.com.

    About Jackson County, NC
    Cashiers, Cherokee, Dillsboro, Sylva, Balsam, Cullowhee, Glenville and Sapphire are the distinct locales that make up Western North Carolina’s Jackson County. Each of these Blue Ridge Mountain towns provides natural beauty that invites visitors to experience the NC Mountains. The majestic mountains harbor miles of hiking trails and waterfalls while charming downtowns are known for shopping, dining, culture, and hometown atmosphere. www.DiscoverJacksonNC.com

    Media Inquiries pwhite@castleladyhawke.com

    Source: Castle Ladyhawke

    Source link

  • Canadian Air Purifier Company Airpura Donates HEPA Air Purifiers to Schools Across North America to Help Fight the Spread of COVID-19

    Canadian Air Purifier Company Airpura Donates HEPA Air Purifiers to Schools Across North America to Help Fight the Spread of COVID-19

    The world has been devastated by the pandemic, but children are among the groups that have fared the worst. School closures have had a detrimental effect on children’s mental health. Children have also been the last group to be approved for vaccinations, making their infection rates comparable to infection rates seen in adults aged 18-49.*
    Airpura, an air purifier manufacturer, wanted to help in the fight and launched a Back-to-School contest asking the public to nominate a school they felt deserved to win air purifiers for the entire school.

    Press Release


    Nov 11, 2021

    Research has shown that COVID-19 is primarily spread through airborne transmission. To stem the spread of the disease, the EPA has recommended the use of portable HEPA air purifiers, particularly in schools.

    Airpura, an air purifier manufacturer, wanted to help in the fight and launched a Back-to-School contest asking the public to nominate a school they felt deserved to win air purifiers for all of the school’s classrooms. www.airpura.com

    More than 1,725 nominations were received from across Canada and the United States.

    Cloverdale Traditional School of Surrey, British Columbia was named the winner of the contest and won 20 HEPA Air purifiers for their school. They received the greatest number of votes from the community to help them win. Cloverdale Traditional School is an elementary school comprised of 300 kids. The school is located on the shared, unceded traditional territory of the Katzie, Semiahmoo and Kawntlen nations and upholds the traditional values of respect, inclusiveness and kind behavior. The contest ended on Sept 27. 2021 and the winners were announced on Sept. 30 2021.

    10 runners up also received one air purifier from Airpura. The following are the schools which were part of the Top 10 were selected on the basis of the number of votes received : Millwood Elementary School( Nova Scotia), Wilbur E Lucas Elementary(Texas), Indian Lake High School(Ohio), Kennedy Elementary(Texas), Southwest Adventist Junior Academy(Texas), Du Pont Middle School(West Virginia), George Greenaway Elementary School(British Columbia), Legacy Middle School(Florida), William J Clinton Elementary(Texas), Pleasant Valley Elementary School(Pennsylvania).

    See the Airpura Back to school contest in full at: https://www.airpura.com/pages/contest

    “Our students, parents, and teachers are so thankful for the Air Purifiers.  Especially during these tough times when health precautions are at a premium, our students and their parents are so happy that we can provide them cleaner air to breathe.”

    Isais Vidal, Principal of Wilbur E. Lucas Elementary School, winner of the second prize

    Airpura has been a leader in pathogen control over the past two decades. SARS-CoV-2 Is the fifth pathogen that Airpura has addressed with their air filtration systems. Throughout the pandemic, Airpura air purifiers have been deployed in the fight against COVID-19 In hospitals, schools, dental clinics and workplaces across the world. Find out how Airpura has been employing groundbreaking research and technology in their air filtration products to combat the growing challenges posed by climate change on the planet’s air quality. These challenges include combatting the toxins from wildfires, excess particulate matter from vehicle emissions, mold from flooding and an increasingly harsh allergy season. https://www.airpura.com

    Press contact: Stacy Singh, Communications and Media Relations. stacy@airpura.com 1-866-505-7872 ext 208

    Helder Pedro, President of Airpura helder@airpura.com 1-866-505-7872 ext 202

    *Source: CDC https://www.ed.gov/coronavirus/improving-ventilation

    Source: Airpura

    Source link